BioNTech SE Noncurrent Financial Liabilities
BioNTech SE (BNTX) had Noncurrent Financial Liabilities of EUR 310.10 million as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:NoncurrentFinancialLiabilities · last filed 2026-03-10
- 2025-12-31: Noncurrent Financial Liabilities 310.10M EUR.
- 2024-12-31: Noncurrent Financial Liabilities 261.60M EUR.
- 2022-12-31: Noncurrent Financial Liabilities 182.30M EUR.
- 2021-12-31: Noncurrent Financial Liabilities 177.70M EUR.
| Period end | Noncurrent Financial Liabilities | Noncurrent Financial Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 310.10M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 261.60M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 182.30M EUR 20-F · filed 2023-03-27 | |
| 2021-12-31 | 177.70M EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | 262.50M EUR 20-F/A · filed 2022-10-26 | 262.52M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 68.90M EUR 20-F · filed 2021-03-30 | |
| 2018-12-31 | 54.22M EUR 20-F · filed 2020-03-31 |